AGP Executive Report
Last update: 8 hours agoInflation & Health Costs: Singapore’s CPI rose 1.7% year-on-year in 1H 2026, with health insurance among the contributors; core inflation also picked up to 1.6% in June as food, services and retail costs edged higher. Public Health Watch: HSA warned consumers to stop buying three products after testing found banned or potent medicinal ingredients, following serious adverse effects reported by users including a 12-year-old. Workplace Safety: Seven people died in work-related traffic accidents in 1H 2026 (including four platform workers), prompting calls to tighten safety for routine tasks, not just high-risk work. Oncology & Biotech: Singapore-based Tikva Allocell raised $8m to push a B7-H3 cell therapy candidate toward Phase 1 trials in Singapore and the US. Wellness & Care Tech: A Woodlands Hospital pilot is reported to reduce hospitalisations and A&E visits for nursing home residents, pointing to more care-at-home models. Health Equity & Access: Singapore’s Cabinet reshuffle included leadership changes relevant to manpower and digital development, as the government continues its leadership transition.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.